NCT07528170Completed
Complications After CT-guided Lung Biopsies at St. Olavs Hospital
Source: ClinicalTrials.gov · Last updated 14 Apr 2026
Brief summary (registry, in English)
At St. Olavs Hospital, a prospective collection of data on complications related to CT-guided lung biopsies has been conducted over several years as part of quality control study. The primary aim of this quality control study is to map complications in all patients who have undergone percutaneous CT-guided lung biopsy at St. Olavs Hospital from May 2012 to December 2023.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1200 (actual)
- First submitted
- 7 Apr 2026
- Start date
- 1 May 2012
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- St. Olavs Hospital
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT07528170
What you commit to
- Study type: Observational
- Participants enrolled: 1200
- From 1 May 2012 to the primary completion date, 31 Dec 2023
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- All patients eligible to a CT-guided needle biopsy of a lung nodule (allcomers)
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.